Stocktoria
RAPID MICRO BIOSYSTEMS, INC. RPID
Nasdaq · stock · Laboratory Analytical Instruments · website · IPO 2021-07-15
RAPID MICRO BIOSYSTEMS, INC. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $33.6M | $28.1M | $22.5M | $17.1M | $23.2M | $16.1M |
| R&D expense | $13.6M | $14.6M | $12.8M | $12.9M | $9.8M | $6.5M |
| Operating income | -$47.4M | -$49.9M | -$56.6M | -$63.2M | -$47.2M | -$30.5M |
| Interest expense | — | — | — | — | $2.6M | $3.4M |
| Income tax | $40,000 | $22,000 | $31,000 | -$576,000 | $91,000 | $134,000 |
| Net income | -$47.1M | -$46.9M | -$52.5M | -$60.8M | -$73.5M | -$37.1M |
| EPS (diluted) | $-1.05 | $-1.08 | $-1.22 | $-1.43 | $-3.94 | $-126.11 |
| Operating cash flow | -$31.1M | -$44.2M | -$45.1M | -$58.5M | -$55.0M | -$31.0M |
| Free cash flow | -$31.9M | -$45.5M | -$46.9M | -$65.3M | -$58.2M | -$31.7M |
| Cash & equivalents | $20.0M | $16.9M | $24.3M | $27.1M | $178.4M | $30.1M |
| Inventory | $17.6M | $20.2M | $20.0M | $21.2M | $15.7M | $9.0M |
| Total assets | $74.9M | $98.2M | $143.5M | $190.7M | $241.2M | $70.0M |
| Total liabilities | $41.6M | $22.8M | $25.5M | $26.5M | $20.2M | $45.2M |
| Shareholders' equity | $33.2M | $75.4M | $118.0M | $164.2M | $221.0M | -$127.0M |
Growth · year-over-year · Revenue CAGR 15.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | +19.7% | +24.6% | +31.4% | -26.3% | +44.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.